Press release
Constipation Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies 2024
Constipation Pipeline
Request a sample and discover the recent advances in Constipation Treatment Drugs @ Constipation Pipeline Report- https://www.delveinsight.com/report-store/constipation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Constipation Pipeline Report
• July 2024- AbbVie- A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age With Functional Constipation (FC). Functional constipation (FC) is a common healthcare problem in children of all ages, potentially due to genetic predisposition, inadequate fiber and fluid intake, and immobility.
• April 2024:- AbbVie announced a study of Phase 2 clinical trials for Linaclotide. A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age With Functional Constipation (FC). There may be higher treatment burden for participants in this trial compared to their standard of care (due to study procedures). Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
• DelveInsight's Constipation pipeline report depicts a robust space with 15+ active players working to develop 15+ pipeline therapies for Constipation treatment.
• The leading companies working in the Constipation Market include Anji Pharma, Yuhan, Theravance Biopharma, RaQualia Pharma, Processa Pharmaceuticals, Abbott, AbbVie`s Inc., Albireo Pharma, Inc., AstraZeneca, Bausch Health Companies Inc., Bayer AG, Cosmo Pharma, and others.
• Promising Constipation Pipeline Therapies in the various stages of development include Linaclotide, Pradigastat Tablets 20mg, Methylnaltrexone, N-methylnaltrexone bromide (MOA-728), Prucalopride, and others.
The Constipation pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Constipation drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the Constipation clinical trial landscape.
Constipation Overview
Constipation is a condition in which you may have fewer than three bowel movements a week; stools that are hard, dry, or lumpy; stools that are difficult or painful to pass; or a feeling that not all stool has passed. In many patients, constipation is associated with sluggish movement of stool through the colon.
Find out more about Constipation Treatment Landscape @ Drugs for Constipation Treatment- https://www.delveinsight.com/sample-request/constipation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Constipation Emerging Drugs Profile
• Pradigastat : Anji Pharma
• YH 12852 : Yuhan
• RQ 00000010 : RaQualia Pharma
• RQ 00433412 : RaQualia Pharma
Constipation Pipeline Therapeutics Assessment
There are approx. 20+ key companies which are developing the therapies for Constipation. The Constipation companies which have their Constipation drug candidates in the most advanced stage, i.e. phase II include, Anji Pharma.
Learn more about the emerging Constipation Pipeline Therapies @ Constipation Clinical Trials Assessment- https://www.delveinsight.com/sample-request/constipation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Constipation Pipeline Report
• Coverage- Global
• Constipation Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Constipation Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I,Phase II, Phase III
• Constipation Companies- Anji Pharma, Yuhan, Theravance Biopharma, RaQualia Pharma, Processa Pharmaceuticals, Abbott, AbbVie`s Inc., Albireo Pharma, Inc., AstraZeneca, Bausch Health Companies Inc., Bayer AG, Cosmo Pharma, and others.
• Constipation Pipeline Therapies- Linaclotide, Pradigastat Tablets 20mg, Methylnaltrexone, N-methylnaltrexone bromide (MOA-728), Prucalopride, and others.
Dive deep into rich insights for new drugs for Constipation Treatment, Visit @ Constipation Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/constipation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Constipation: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Constipation- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug name : Company name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Pradigastat : Anji Pharma
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. RQ 00000010: RaQualia Pharma
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. RQ 00433412 : RaQualia Pharma
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Constipation Key Companies
21. Constipation Key Products
22. Constipation - Unmet Needs
23. Constipation - Market Drivers and Barriers
24. Constipation - Future Perspectives and Conclusion
25. Constipation Analyst Views
26. Constipation Key Companies
27. Appendix
List of Top Selling Market Research Reports in 2024
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Chronic Neuropathic Pain Market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Hydrocephalus Treatment Market- https://www.delveinsight.com/report-store/hydrocephalus-market
Cancer Therapy Market- https://www.delveinsight.com/report-store/cancer-therapy-market
Glaucoma Market- https://www.delveinsight.com/report-store/glaucoma-market
Methicillin-resistant Staphylococcus Aureus Mrsa Infection Market- https://www.delveinsight.com/report-store/methicillin-resistant-staphylococcus-aureus-mrsa-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Polycystic Ovarian Syndrome Market- https://www.delveinsight.com/report-store/polycystic-ovarian-syndrome-market
Radiodermatitis Market- https://www.delveinsight.com/report-store/radiodermatitis-market
Rhinosinusitis Market- https://www.delveinsight.com/report-store/rhinosinusitis-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
Wilms Tumor Market- https://www.delveinsight.com/report-store/wilms-tumor-market
Hidradenitis Suppurativa Market- https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
Uveitis Market- https://www.delveinsight.com/report-store/uveitis-market
Venous Thromboembolism Market- https://www.delveinsight.com/report-store/venous-thromboembolism-market
Beta Thalassemia Market- https://www.delveinsight.com/report-store/beta-thalassemia-market
Cold Agglutinin Disease Market- https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-market
Postpartum Depression Market- https://www.delveinsight.com/report-store/postpartum-depression-ppd-market
Radiation Dermatitis Market- https://www.delveinsight.com/report-store/radiation-dermatitis-market
Synovial Sarcoma Market- https://www.delveinsight.com/report-store/synovial-sarcoma-market
Tendinopathy Market- https://www.delveinsight.com/report-store/tendinopathy-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Diabetic Nephropathy Market- https://www.delveinsight.com/report-store/diabetic-nephropathy-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Pcsk9 Inhibitors Market- https://www.delveinsight.com/report-store/pcsk9-inhibitors-market
Respiratory Syncytial Virus Market- https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
Chemotherapy Induced Neutropenia Market- https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Immune Thrombocytopenia Market- https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Cystic Fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Post Operative Pain Management Market- https://www.delveinsight.com/report-store/post-operative-pain-management-market
Primary Biliary Cholangitis Market- https://www.delveinsight.com/report-store/primary-biliary-cholongitis-pbc-market
Progressive Supranuclear Palsy Market- https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
Membranous Nephropathy Market- https://www.delveinsight.com/report-store/membranous-nephropathy-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Diabetic Retinopathy Market- https://www.delveinsight.com/report-store/diabetic-retinopathy-market
Post Operative Pain Market- https://www.delveinsight.com/report-store/postoperative-pain-market
Genital Herpes Market- https://www.delveinsight.com/report-store/genital-herpes-market
Axillary Hyperhidrosis Market- https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market
About DelveInsight
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Constipation Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies 2024 here
News-ID: 3658570 • Views: …
More Releases from DelveInsight Business Research LLP
Oral Mucositis Pipeline Insights, Treatment Drugs, Clinical Trials, and Companie …
(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ Oral Mucositis companies continuously working towards developing 10+ Oral Mucositis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
To explore more information on the latest breakthroughs in the Oral Mucositis Pipeline treatment landscape of the report, click here @ Oral Mucositis Pipeline Outlook- https://www.delveinsight.com/report-store/oral-mucositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the…
Alpha-1 Antitrypsin Deficiency Pipeline Insight, Treatment Drugs, Clinical Trial …
DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers the Alpha-1 Antitrypsin Deficiency pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alpha-1 Antitrypsin Deficiency pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample…
Cirrhosis Pipeline Insights, Clinical Trials, Treatment Drugs, and Companies 202 …
DelveInsight's, "Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Cirrhosis pipeline landscape. It covers the Cirrhosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances in Cirrhosis Treatment…
Myositis Clinical Trials, Pipeline Insights, and Companies 2024
DelveInsight's, "Myositis Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Myositis pipeline landscape. It covers the Myositis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances in Myositis Treatment…
More Releases for Constipation
Constipation Treatment Market Segmented by Application,Technology
Constipation treatment market is segmented on the basis of type, treatment, method of administration, and end use. By type, the global constipation treatment market has been categorized into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC). On the basis of treatment, the global constipation treatment market has been categorized into pharmacological treatment and non-pharmacological treatment, which comprises bowel training for constipation relief, fluid intake,…
Constipation Treatment Market: Views Sought On New Approach
High prevalence rate in North America due to increasing adoption of unhealthy lifestyle characterized by growing consumption of fast food is leading to increasing obesity and other related health issues. This inadvertently leads to high incidence rate of constipation in the region.
According to the American Society of Interventional Pain Physicians, the U.S. accounts for around 80% of the global opioids consumption. According to an article published in the American Gastroenterological…
Constipation Treatment Market Opportunity Analysis, 2018-2026
Constipation is a disorder that causes issues related to clearing of the bowels and usually leads to hardened feces. It is especially prevalent among the elderly and women. Common symptoms of constipation include lumpy or hard stools, lower abdominal discomfort, straining to have bowel movements, feeling of blockage in rectum that prevents bowel movements, and infrequent bowel movements. Factor that can lead to constipation are aging, dehydration, little or no…
Constipation Pharmaceutical and Healthcare Pipeline Review H1
Summary
Constipation refers to the infrequent or difficult passing of stool. Constipation occurs when bowel movements become difficult or less frequent. Symptoms of constipation include swollen abdomen or abdominal pain, pain and vomiting. The predisposing factors include eating disorders, irritable bowel syndrome, and hypothyroidism, overuse of laxatives (stool softeners) which, over time, weaken the bowel muscles, stress, inadequate water intake and inadequate fiber in the diet. Treatment includes use of laxatives…
Opioid Induced Constipation Treatment Market
Opioids are medications that work on opioid receptors in order to generate morphine-like effects. These are mainly used therapeutically to relieve pain and are often abused by individuals addicted to them. Opioids comprises opiates, a conventional name that points to drugs that are derivatives of opium, including morphine. Constipation means bowel actions that are sporadic or hard to go by. The fecal matter is often dry and hard. Some of…
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation…
